batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Zynlonta gets squeezed 13 March 2024 Caribou joins Gilead and Astra in CLL-1 12 March 2024 Third pivotal trial for Moderna’s personalised immunotherapy 11 March 2024 Inhibrx breathes life into Ox40 8 March 2024 Zymeworks wakes up to the Enhertu threat 7 March 2024 Boundless enthusiasm for CHK1 7 March 2024 AACR 2024 preview – more companies pile into popular mechanisms 6 March 2024 Gritstone investors get pre-Granite jitters 4 March 2024 Load More